Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor

Detalles Bibliográficos
Autores principales: Miyamoto, Yasunori, Honda, Akira, Yokose, Seiji, Nagata, Mariko, Miyamoto, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967662/
https://www.ncbi.nlm.nih.gov/pubmed/35371450
http://dx.doi.org/10.1093/ckj/sfab266
_version_ 1784678878625660928
author Miyamoto, Yasunori
Honda, Akira
Yokose, Seiji
Nagata, Mariko
Miyamoto, Jiro
author_facet Miyamoto, Yasunori
Honda, Akira
Yokose, Seiji
Nagata, Mariko
Miyamoto, Jiro
author_sort Miyamoto, Yasunori
collection PubMed
description
format Online
Article
Text
id pubmed-8967662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89676622022-03-31 Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor Miyamoto, Yasunori Honda, Akira Yokose, Seiji Nagata, Mariko Miyamoto, Jiro Clin Kidney J Letter to the Editor Oxford University Press 2021-12-13 /pmc/articles/PMC8967662/ /pubmed/35371450 http://dx.doi.org/10.1093/ckj/sfab266 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor
Miyamoto, Yasunori
Honda, Akira
Yokose, Seiji
Nagata, Mariko
Miyamoto, Jiro
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title_full Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title_fullStr Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title_full_unstemmed Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title_short Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
title_sort weaning from concentrated ascites reinfusion therapy for refractory ascites by sglt2 inhibitor
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967662/
https://www.ncbi.nlm.nih.gov/pubmed/35371450
http://dx.doi.org/10.1093/ckj/sfab266
work_keys_str_mv AT miyamotoyasunori weaningfromconcentratedascitesreinfusiontherapyforrefractoryascitesbysglt2inhibitor
AT hondaakira weaningfromconcentratedascitesreinfusiontherapyforrefractoryascitesbysglt2inhibitor
AT yokoseseiji weaningfromconcentratedascitesreinfusiontherapyforrefractoryascitesbysglt2inhibitor
AT nagatamariko weaningfromconcentratedascitesreinfusiontherapyforrefractoryascitesbysglt2inhibitor
AT miyamotojiro weaningfromconcentratedascitesreinfusiontherapyforrefractoryascitesbysglt2inhibitor

Ejemplares similares